AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Eli Lilly's Surge: Navigating Success and Demand
This chapter explores Eli Lilly's impactful developments with Terzepatide and Zepbound, contributing $5 billion in revenue. It also addresses the challenges the company faces in meeting the growing demand for these medications and its future expansion plans.